[EN] FUSED PYRAZINE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE PYRAZINE FUSIONNÉS EN TANT QU'INHIBITEURS DE KINASE
申请人:UCB PHARMA SA
公开号:WO2010052448A2
公开(公告)日:2010-05-14
A series of quinoxaline derivatives, and analogues thereof, which are functionalised further by a substituted phenyl or pyridinyl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.